Brain study aims to Fine-Tune Parkinson's treatment

NCT ID NCT05658302

Recruiting now Knowledge-focused Sponsor: University of Minnesota Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how deep brain stimulation (DBS) affects brain activity in 30 people with Parkinson's disease. Researchers will measure brain signals during movement and thinking tasks, with and without DBS or medication. The goal is to understand how different brain areas work together, which could help improve DBS therapy in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: deep brain stimulation (DBS) and L-dopa
What this could lead to: If successful, this could lead to better-targeted deep brain stimulation therapies for Parkinson's disease, improving movement and thinking problems.
What could go wrong: This is a small, early-stage study focused on understanding brain signals, not testing a new treatment. Results may not directly improve patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE

Contacts and locations

Locations

University Of Minnesota
RECRUITING

Minneapolis, Minnesota, 55445, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.